Robichaud GA - Search Results

1

The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease.

O'Brien P, Morin P Jr, Ouellette RJ, Robichaud GA. O'Brien P, et al. Among authors: robichaud ga. Cancer Res. 2011 Dec 15;71(24):7345-50. doi: 10.1158/0008-5472.CAN-11-1874. Epub 2011 Nov 29. Cancer Res. 2011. PMID: 22127921 Review.

2

Investigation of interaction between Pax-5 isoforms and thioredoxin using de novo modelling methods.

Cuperlovic-Culf M, Robichaud GA, Nardini M, Ouellette RJ. Cuperlovic-Culf M, et al. Among authors: robichaud ga. In Silico Biol. 2003;3(4):453-69. In Silico Biol. 2003. PMID: 14965345

3

Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells.

Robichaud GA, Nardini M, Laflamme M, Cuperlovic-Culf M, Ouellette RJ. Robichaud GA, et al. J Biol Chem. 2004 Nov 26;279(48):49956-63. doi: 10.1074/jbc.M407171200. Epub 2004 Sep 22. J Biol Chem. 2004. PMID: 15385562 Free article.

4

Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element.

Robichaud GA, Perreault JP, Ouellette RJ. Robichaud GA, et al. Nucleic Acids Res. 2008 Aug;36(14):4609-20. doi: 10.1093/nar/gkn432. Epub 2008 Jul 10. Nucleic Acids Res. 2008. PMID: 18617575 Free PMC article.

5

Coordinated expression of Pax-5 and FAK1 in metastasis.

Crapoulet N, O'Brien P, Ouellette RJ, Robichaud GA. Crapoulet N, et al. Among authors: robichaud ga. Anticancer Agents Med Chem. 2011 Sep;11(7):643-9. doi: 10.2174/187152011796817637. Anticancer Agents Med Chem. 2011. PMID: 21707507 Review.

6

MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis.

Harquail J, Benzina S, Robichaud GA. Harquail J, et al. Among authors: robichaud ga. Cancer Biomark. 2012;11(6):269-80. doi: 10.3233/CBM-120291. Cancer Biomark. 2012. PMID: 23248185 Review.

7

Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.

Cormier K, Harquail J, Ouellette RJ, Tessier PA, Guerrette R, Robichaud GA. Cormier K, et al. Among authors: robichaud ga. Anticancer Agents Med Chem. 2014 Jan;14(1):35-45. doi: 10.2174/18715206113136660333. Anticancer Agents Med Chem. 2014. PMID: 24041228

8

Breast Cancer Malignant Processes are Regulated by Pax-5 Through the Disruption of FAK Signaling Pathways.

Benzina S, Harquail J, Guerrette R, O'Brien P, Jean S, Crapoulet N, Robichaud GA. Benzina S, et al. Among authors: robichaud ga. J Cancer. 2016 Oct 22;7(14):2035-2044. doi: 10.7150/jca.15200. eCollection 2016. J Cancer. 2016. PMID: 28070224 Free PMC article.

9

Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes.

Benzina S, Beauregard AP, Guerrette R, Jean S, Faye MD, Laflamme M, Maïcas E, Crapoulet N, Ouellette RJ, Robichaud GA. Benzina S, et al. Among authors: robichaud ga. Oncotarget. 2017 Feb 14;8(7):12052-12066. doi: 10.18632/oncotarget.14511. Oncotarget. 2017. PMID: 28076843 Free PMC article.

10

Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors.

Harquail J, LeBlanc N, Landry C, Crapoulet N, Robichaud GA. Harquail J, et al. Among authors: robichaud ga. J Mammary Gland Biol Neoplasia. 2018 Sep;23(3):177-187. doi: 10.1007/s10911-018-9404-4. Epub 2018 Jul 21. J Mammary Gland Biol Neoplasia. 2018. PMID: 30032344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page